In vitro modeling of autologous and non-autologous NK : CML cell-interactions demonstrated that IFN-α treatment stimulated NK cytolytic activity (72, 73). This evidence concerns the gene IFNA2 and chronic myelogenous leukemia, BCR-ABL1 positive.